| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Unité De Recherche Centre de pneumologie, Hôpital Laval, Université Laval, Québec, Canada
CORRESPONDENCE: F. Sériès, Centre de pneumologie, Hôpital Laval, 2725 Chemin Sainte Foy, Sainte Foy, G1V 4G5, Canada. Fax: 418 6554762
Keywords: diurnal somnolence, effective pressure level, positive pressure variability
Received: October 20, 1998
Accepted May 25, 2001
 |
Abstract |
|---|
 TOP Abstract Material and methodsResultsDiscussionReferences |
|---|
Thirty-three newly treated sleep apnoea hypopnoea syndrome (SAHS) patients were randomly allocated to conventional or auto-CPAP therapy. Six patients of each treatment group were classified as having sleep stage- and body position-dependent obstructive breathing abnormalities according to the results of the baseline sleep study.
After 3 weeks of treatment, the Epworth sleepiness score tended to be higher (p=0.08) and the ability to stay awake lower (p=0.02) in patients with dependent breathing abnormalities treated with fixed CPAP, than in the other patients. The effective pressure/time index was significantly lower in sleep stage- and body position-dependent patients treated with fixed CPAP, than in the other patients (p=0.02). The number of hours the machine was turned on and a positive pressure applied, tended to be smaller in dependent patients treated with fixed CPAP than in independent patients of this treatment group and in patients treated with auto-CPAP. A night-to-night variability index (VI) of positive pressure changes was obtained in the auto-CPAP group. This index significantly decreased with time in the dependent patients while it remained unchanged in the independent group.
It is concluded that auto-continuous positive airway pressure may have specific indications in a subset of obstructive sleep apnoea patients with sleep stage- and body position dependent nocturnal breathing abnormalities.
Nasal continuous positive airway pressure (CPAP) is one of the most effective treatments of the sleep apnoea/hypopnoea syndrome (SAHS). The effective positive pressure level (Peff) is conventionally identified during attended or unattended titration sleep studies and indicates the pressure level required to normalize sleep and respiration in all sleep stages and body positions during the first treatment night. However, this pressure level is influenced by several physiological and clinical situations, including sleep stages, changes in body, neck and jaw position, variations in upper airway vascular tone, hysteresis of the upper airway, duration of CPAP therapy, and weight loss 1–7. Because of the aforementioned factors, positive pressure requirements may dramatically change over time. CPAP therapy should take into account for the intra-night and inter-night variability in positive pressure requirements. This has led to the development of automatic positive pressure devices that have the ability to continuously adapt the positive pressure level during the night.
Only a few studies have been conducted to explore the applicability and accuracy of these newly developed apparatus, most of those performed having been conducted in a sleep laboratory or in hospital 8–10 instead of the home environment 11, 12. Most studies demonstrated a normalization of sleep and respiratory variables during auto-CPAP therapy with a similar improvement in subjective and objective diurnal sleepiness and in neuropsychological performances compared to fixed CPAP 12, 13. With these auto-CPAP machines, a significant percentage of total sleep time can be spent below the effective pressure level 8, 11, with significant changes in the positive pressure level within the different sleep stages and body positions 12, 13. Another important potential advantage of auto-CPAP therapy is that it is associated with an increase in short term treatment compliance 12, 13.
Besides these potential benefits of auto-CPAP therapy, it must be acknowledged that the specific place of auto-CPAP therapy in SAHS treatment strategy is not clearly defined, i.e. should it be prescribed in every patient or only in a subset of patients who would particularly benefit from this new therapeutic alternative? According to the present authors' experience with auto-CPAP and knowing the influence of sleep stages and body positions on the required positive pressure needs, it was hypothesized that patients who have sleep stage- and/or body position-dependent obstructive breathing abnormalities would be more likely to benefit from auto-CPAP therapy.
The aim of the present study was to evaluate the influence of sleep stage- and body position-dependence of sleep apnoea on treatment efficacy and compliance between conventional CPAP and auto-CPAP therapy. For this purpose, since the sample sizes of recently published trials on auto-CPAP were too small to conduct the present study 12, 13, the patients who participated to those previous studies were pooled together and a new cohort of patients was enrolled.
|
Material and methods |
|---|
|
TOPAbstractMaterial and methodsResultsDiscussionReferences |
|---|
Sleep studies
Sleep recording consisted of the continuous acquisition of: electroencephalogram (C4A1, C3A2, O2A1); electroculogram (EOG); submental and anterior tibialis electromyogram (EMG); electrocardiogram (ECG); combined oro-nasal flow with thermistors placed in front of the nares and the mouth (ONT 2, Grass instruments, Astromed, Longueuil, PQ, Canada); thoracoabdominal movements with inductive plethysmography (Respitrace®, Ambulatory monitoring, Arsdley, NY, USA) calibrated with the isovolume method 14; arterial oxyhaemoglobin saturation with an ear oximeter (504 pulse oximeter, Criticare systems, Waukesha, WI, USA); and breathing noises with two microphones placed at the head of the bed 15. Body position was checked during the sleep recordings by the attending technician, according to continuous infrared monitoring. During CPAP nights, flow was measured via a pneumotachograph connected to the nasal CPAP mask.
Protocol
Diurnal sleepiness was subjectively assessed by the Epworth sleepiness score (ESS) 16, and the ability to stay awake with the Maintenance of wakefulness test (MWT) 17, before initiating CPAP therapy. Every patient had a conventional titration sleep study to determine the Peff level. They were then randomly allocated to fixed (n=24) or auto-CPAP (n=24) therapy using the same auto-CPAP machine (Morphée Plus/Cloudnine, Nelcorr Puritan Benett, Minneapolis, MN, USA) for 3 weeks. For the 40 patients who participated in the aforementioned previous auto-CPAP studies, the constant and auto-CPAP groups were paired for the apnoea/hypopnoea index (AHI) and body mass index (BMI) (n=8) or for Peff (n=12). The eight additional subjects were paired for Peff.
In the conventional CPAP group, the machine was set at Peff and used in the constant mode. In the auto-CPAP group, the Morphée Plus setting requires the determination of a reference pressure on each side of which the pressure is allowed to change inside upper and lower limits that are separately chosen by the physician. Reference pressure was set at the Peff value, with upper and lower pressure limits set at +2/–4 cmH2O in eight subjects, and +3/–4 cmH2O in the 12 others. A control sleep study was obtained at the end of the CPAP trial using the machine and the pressure setting prescribed for the three previous weeks. ESS score and MWT test were obtained during the day following the control sleep study.
Data and statistical analysis
Sleep and respiratory variables were manually interpreted according to standard criteria 18, 19. Treatment compliance was evaluated by the time the machine was turned on (machine running time), the time a positive pressure was applied (positive pressure-time), and their ratio (effective pressure time index). Patients were classified as having sleep stage- or body position-dependent nocturnal breathing abnormalities when there was a minimum of 100% difference in the apnoea/hypopnoea index between the different sleep positions (lateral, supine) in nonrapid eye movement (REM) sleep or between stages I and II, and REM in the same sleep position. Patients were defined as having sleep stage- and body position-dependent nocturnal breathing abnormalities when both sleep stage-dependence criteria were met.
In patients of the auto-CPAP group, the amount of pressure delivered at the different pressure levels was assessed by a print out of the percentage of the positive pressure-time spent at the different pressure levels for each treatment night during the 3 weeks of home CPAP therapy. The degree of pressure changes was quantified by the VI, which took into account the percentage of positive pressure time spent at the different pressure levels. The same formula that is used to determine the variance of a frequency variable was used: VI=
i (i–A)2·Pi, where i represents the positive pressure value from 4–20 cmH2O in 2 cmH2O increments, Pi is the percentage of positive pressure time spent at the different positive pressure levels, and A=i I·Pi. According to this index calculation, VI is 0 if the whole night was spent at the same pressure level and 5 if the time spent at the different pressure levels is identical. The maximal possible value of VI is 9 and corresponds to the situation where 50% of the treatment time is spent at the two extreme pressure values respectively.
The different analysed parameters were compared using a two-way ANOVA to evaluate the interaction effects of treatment mode and sleep stage/body position-dependence status. Parameters measured at baseline and after treatment were compared with a repeated measure design. Normality of variance assumptions were verified to validate statistical tests. The distribution of total sleep time between different sleep stages was transformed with an arcsin function and expressed as a percentage. Statistical significance was inferred for p-values<0.05.
|
Results |
|---|
|
TOPAbstractMaterial and methodsResultsDiscussionReferences |
|---|
Patients of the two treatment groups (constant and auto-CPAP) had identical age, body mass index, apnoea/hypopnoea and sleep fragmentation indices, and Peff values (tables 1 and 2
). Subjective and objective baseline assessment of diurnal sleepiness and Peff level were similar in these two groups (table 2). No difference was found in these variables between patients with or without sleep stage/body position-dependent breathing abnormalities in each treatment group.
|
|
). At the end of the treatment period, patients treated with fixed CPAP who had dependent breathing abnormalities demonstrated more daytime sleepiness compared to the other patients of this treatment group and to those of the auto-CPAP group, as suggested by the higher Epworth sleepiness score (p=0.08) and lower ability to stay awake (p=0.02) (table 2). Similarly, diurnal sleepiness improved in dependent and independent patients of the auto-CPAP treatment group. In the auto-CPAP group, the percentage of positive pressure-time that was spent below Peff during home CPAP trial was significantly greater in the dependent group than in the independent group (p=0.009).
The machine running time was similar in the fixed and auto-CPAP treatment groups. However, the positive pressure-time and the effective pressure time index were significantly less in the fixed CPAP group than in the auto-CPAP group (p=0.006). The machine running time, positive pressure-time (fig. 1a), and effective pressure-time index (fig. 1b) were smaller in patients of the fixed CPAP with dependent breathing disorders with than in the other groups. This difference did not reach significance for the first two variables but was significant for the third one (p=0.02).
|
No difference was found in VI between sleep stage/body position dependent and independent patients for the overall treatment period (5.9±2.2 and 5.3±2.6, respectively, p=0.12). This index was found to significantly decrease with time in the dependent patients while it remained unchanged in the independent group (fig. 2).
|
|
Discussion |
|---|
|
TOPAbstractMaterial and methodsResultsDiscussionReferences |
|---|
The criteria that were used to define body position-dependence is the same as that previously used by Shepard and coworkers 20, 21. Interestingly, these authors found that, in a retrospective study of 100 patients, 43% of patients with body position-dependent nocturnal breathing disorders also had a sleep stage-dependence according to the criteria that were used in the present study; therefore, the prevalence of sleep stage- and body position-dependence in their study population was 21%, which is very close to that observed in the present study in those patients where this dependency could be analysed (25%).
The present results suggest that CPAP compliance and the benefits of treatment on neuropsychological variables are improved with auto-CPAP therapy in patients with sleep stage- and/or body position-dependent nocturnal breathing disorders, compared to fixed CPAP. This is of primary importance when objective compliance to CPAP therapy is poor; only 46% of patients treated with fixed CPAP apparatus use it at least 4 h·day–1 22. According to the prevalence of body position- and sleep stage-dependence that were observed in the present study, auto-CPAP therapy may be more effective than conventional CPAP treatment in 25% of obstructive sleep apnoea (OSA) patients. On the other hand, the present results suggest that in patients with no such body position- and sleep stage-dependence, auto-CPAP therapy may not bring additional benefits compared to fixed CPAP. Therefore, auto-CPAP therapy may have specific indications in a subset of OSA patients, but is obviously not more effective than conventional CPAP in the majority of sleep apnoea patients. These parameters should be taken into account in any clinical trial comparing auto-CPAP and conventional CPAP efficiencies.
Body position and sleep stage have been shown to significantly influence the positive pressure level that abolishes obstructive breathing abnormalities 1, 2. The present authors are aware that several other factors also contribute to determine the positive pressure needs, and potentially, the changes in positive pressure requirements within the night, and from one night to another 3–5. This can account for the important scatter in VI that was found in both groups (fig. 2). However, it is particularly interesting to note that the behaviour of this index with time, differed between the groups with different sleep stage- and/or body position-dependence status, with the VI decreasing with time in patients with dependent breathing abnormalities. Several factors can contribute to the decrease in VI over time such as the greater stability in body position during CPAP therapy 23 and the improvement in upper airway shape and/or dimension 24. Several other factors may obviously be involved that remain to be investigated.
The observation that VI progressively decreases in dependent patients, to become similar to that of the independent group within 3 weeks of treatment, suggests that the benefits of auto-CPAP machines may be limited during the first weeks of treatment. Further studies should be conducted to analyse if VI values, and its changes during the course of CPAP therapy, may bring additional information on auto-CPAP behaviour, independently of the sleep stages- and or body position-dependent and independent status.
It is concluded that patients with body position- and/or sleep stage-dependency of nocturnal breathing disturbances, may benefit more from auto-continuous positive airway pressure therapy than from fixed continuous positive airway pressure, at least during the initial course of their treatment. Long-term prospective, randomized trials are needed to determine if additional factors can help to identify patients whose compliance and clinical response would be enhanced by using auto-continuous positive airway pressure devices and to investigate if positive pressure variations may be helpful in identifying them.
|
References |
|---|
|
TOPAbstractMaterial and methodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  J. Rigau, J. M. Montserrat, H. Wohrle, D. Plattner, M. Schwaibold, D. Navajas, and R. Farre Bench model to simulate upper airway obstruction for analyzing automatic continuous positive airway pressure devices. Chest, August 1, 2006; 130(2): 350 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Noseda, C. Kempenaers, M. Kerkhofs, S. Braun, P. Linkowski, and E. Jann Constant vs Auto-Continuous Positive Airway Pressure in Patients With Sleep Apnea Hypopnea Syndrome and a High Variability in Pressure Requirement Chest, July 1, 2004; 126(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Senn, T. Brack, F. Matthews, E. W. Russi, and K. E. Bloch Randomized Short-term Trial of Two AutoCPAP Devices versus Fixed Continuous Positive Airway Pressure for the Treatment of Sleep Apnea Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1506 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. o-D. L. Lattimore, D. S. Celermajer, and I. Wilcox Obstructive sleep apnea and cardiovascular disease J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1429 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Farre, J. M. Montserrat, J. Rigau, X. Trepat, P. Pinto, and D. Navajas Response of Automatic Continuous Positive Airway Pressure Devices to Different Sleep Breathing Patterns: A Bench Study Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 469 - 473. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
) and positive pressure time (
), and b) and effective pressure time index in each treatment group, depending on their sleep stage/body position-dependency. The effective pressure time index is defined as the ratio of the number of hours a pressure is delivered to the number of hours the machine is turned on. The parameters measuring treatment duration tended to be lower in dependent patients treated with fixed continuous positive airway pressure (CPAP) but these differences did not reach significance. The effective pressure index was significantly lower in this group compared to others. *: significant difference (p<0.05) between indicated groups.